Jessica Rose
speaker
147 appearances
1 recordings
1 series
first heard Nov 2024
last heard Nov 2024
Jessica Rose’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
There's no way, I shouldn't say no way because genes are funny that way, but that's not something typically that you would see in a Corona bat virus.
Well, I don't know if it would be typical. I don't think it would be typical. But it certainly is strange that there do seem to be quite a large number of these. There are at least two papers I can think of off the top of my head that are peer-reviewed. They're sitting on PubMed right now, published, that actually map many, many, many of these. And some of them are actually linked to...
the female reproductive system as well. But, but I should tell everyone about self-reporting RNA before I run out of time.
Hold on, before you do, before you do, I want to make sure we hang on and Dr. Craig, I want to make sure if you don't have anything to say about what Jessica just, she was dropping bombs all over the place there. And I want to make sure you, do you have a reaction to any of that?
Okay. All right, Jessica, keep going.
I'm just, forgive me, I'm looking for the papers off the top of my head if I can read them to people about the molecular mimicry issue. Darn it. I do. No, I have it. So I can't, I won't even think about sharing my screen. That's too complicated. So there's a paper that was published in 2020.
It's called is molecular mimicry, the culprit and autoimmune hemolytic anemia affecting patients with COVID-19. And it's, some other questions, but I implore everyone to read this. And there's also potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins that was published in 2022 in viruses.
So just to, you know, confirm what I'm saying is true, that there are papers that people have written, you know, that document this phenomenon.
mRNA, replicating mRNA. Get there.
All right, guys, sit down. You're going to have to. So I just recently came back from a trip to Japan with some colleagues. Lawyers, doctors, scientists, because we had the ear of some Japanese parliamentarians on the subject matter of the self-amplifying mRNA LNP technology.
And the reason why we went there was because they were about to launch it into the elderly population starting on October 1st. We did reach people. I think that we actually made a difference. They did go ahead with administering these products. Now, this is a COVID SARS product. This has the spike gene inside, and I'll tell you all about that now. In my opinion, it's completely moot.
Nobody needs to be injected with this stuff because everybody's had an experience with it and a challenge and or a challenge. But the uptake, the good news is the uptake was apparently quite low. So this is very good news from the point of view of people's awareness having improved.
However, because of the nature of these products, you know, it kind of makes me wonder if it's not quote unquote too late. So let me tell you what this is and how it's different from the modified mRNA. It does utilize the same lipid nanoparticle technology. The only thing that's different in the formulation that has four fats is the cationic lipid.
So it's still an ionizable cationic lipid, which is the only thing you guys need to know is that it's highly toxic. And those toxicity issues haven't been resolved. So all the compendial standard issues exist. And the good manufacturing practice issues are probably going to carry right over with these new products.
We know how careful they were with formulating and manufacturing these modified mRNA products. we can see because they have residual DNA in them. So we can assume, I'm speculating here, but we can assume that we're going to have similar problems, at least from the point of view of the lipid nanoparticles with this new stuff. So now let me scare you.
What they've done is they've taken something called an alpha virus. This is a genus of viruses in the family Togaviridae. Don't ask me how I remembered that. But these geniuses have borrowed a wonderful tool that these alpha viruses use to self-replicate their own genetic material called an RNA-dependent RNA polymerase.
So, like many things in biology, we humans look at them, we marvel at it, and then we try and mimic it in the lab for, like, making therapeutic products. I call it mad scientism. So just like plasmids in bacteria are used in biotech, what these people decided to do was to take this alpha virus and this copying machine enzyme
extract out the subgenomic components, which are the bits of the alpha virus that it uses to give it infrastructure. By the way, the virus that they used is called Venezuelan equine encephalitis virus, and that's as scary as it sounds.
I was going to say, the toga viruses is German measles and equine encephalitis. That's what they cause.
The actual Venezuelan one, yeah, which is the only one we don't have up here in Southern California. We have everything else.
Showing 81–100 of 147 · page 5 of 8
← Previous
Next →